|
 |
Diagnosing Alzheimer's
(Source: Mayo Clinic) - It's a common belief that the only way to diagnose Alzheimer's disease is by means of a post mortem brain autopsy. But that's not necessarily true.
Alzheimer's Drug Trial Launched
(Source: Boston Business Journal) - Epix Pharmaceuticals announced that it has launched a mid-stage human clinical for a potential Alzheimer's disease treatment.
Communication Between Memory Areas
(Source: Science Daily) - The question of how the brain stores memories still remains largely unexplained. Many researchers favor the "Consolidation Theory."
Approval Received for AL-108
(Source: CNN Matthews) - Allon Therapeutics announced that they have received Institutional Review Board approval to begin enrolling patients for a Phase II human clinical trial evaluating the company's product AL-108. The trial will investigate the of the drug's value for improving cognitive function in patients with Mild Cognitive Impairment, often a pre-cursor to Alzheimer's disease.
Guidelines for the Treatment of Psychiatric Disorders
(Source: JAMA) - Defined as "a set of patient care strategies developed to assist physicians in clinical decision making," practice guidelines provide useful, clinically relevant, and evidence-based summaries of how to help patients.
Anti-Hypertensive Drugs May Reduce Alzheimer's
(Source: EurekAlert!) - Research conducted by Dr. Gulio Maria Pasinetti at the Mount Sinai School of Medicine in New York has identified specific anti-hypertensive agents that may prevent cognitive decline and amyloid neuropathology associated with Alzheimer's disease.
|
|